Dompé: excellence in healthcare innovation
Dompé is a leading Italian biopharmaceutical company focusing on the development of innovative treatment solutions for rare and often orphan diseases. Dompé pursues this objective by promoting and actively participating in a network made up of the best names in each activity of the pharmaceutical industry, from research to development, from production to marketing.
The company concentrates its efforts in areas with therapeutic needs that are still unmet, such as ophthalmology, oncology, diabetes and organ transplantation.
Founded in 1940, Dompé has its headquarters in Milan, its major industrial and biotechnology research site in L’Aquila and another Research & Development unit in Naples.
As part of its international development strategy, Dompé opened in 2014 its offices in New York to coordinate the R&D activities in North America. In 2015, offices were opened in Tirana, where the Group markets its Primary Care product portfolio, and in Barcelona, in order to follow the ongoing collaborations with research centres in Spain aimed at developing innovative biotechnology solutions.
Research at the heart of the Dompé strategy: from L’Aquila to the international network
Dompé production and research activities are concentrated at the L’Aquila site. Founded in 1993, it occupies an area of over 30,000 m2 and is one of the leading centre of excellence in Central and Southern Italy, recognised at national level, as well as internationally.
To date, Dompé has consolidated its R&D commitment by promoting 21 clinical trials involving 1,200 patients around the world. These have been conducted through collaboration with an international network of 200 research centres.
In 2016, the Group will invest €54.6 million in Research & Development, i.e. 30% of its revenues.
Dompé commitment to Primary Care
Dompé is today one of the best known companies in the Italian Primary Care and self-medication market. Thanks to a strategic approach based on incremental innovation, its portfolio is marketed in more than 40 countries around the world. In particular, the Group has a consolidated extensive expertise in areas such as respiratory and pain/inflammation conditions, for which it offers some of the most used solutions in Italy.
Address: Via San Martino, 12-12/a, 20122 – Milano,Italy
Tel: +39 02 583831